1. Home >
  2. M&A >
  3. Growth Capital >
  4. France >
  5. Bridgepoint Invests In BALT

Investment Summary

Bridgepoint Invests In BALT

On September 25, 2015, private equity firm Bridgepoint invested in medical products company BALT

Investment Highlights
  • This is Bridgepoint’s 3rd transaction in the Medical Products sector.
  • This is Bridgepoint’s 24th transaction in France.

Investment Summary
Date 2015-09-25
Target BALT
Sector Medical Products
Investor(s) Bridgepoint
Deal Type Growth Capital
Advisor(s) Natixis Corporate & Investment Banking (Financial)

Target

BALT

Montmorency, France
BALT designs, manufactures and distributes 'neuroendovascular' devices such as stents, coils, and catheters used to prevent and treat brainstrokes and aneurysms. BALT was founded in 1977 and is based in Montmorency, France.

Search 205,615 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Bridgepoint

London, United Kingdom

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1984
PE ASSETS 28.2B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Bridgepoint is a large European private equity firm that invests in middle-market companies across a broad range of industries with an enterprise value of €200 - €1000 million. Prospective transaction situations include buyouts, buy-ins, growth financings, consolidations, and take privates. The firms invest in the range of €75 - €400 million transaction. Bridgepoint Development Capital specializes in investments in businesses valued up to a €150 million, taking equity stakes of between €10 million and €75 million. General sectors of interest include consumer products and services, retail, financial services, healthcare, media, technology, industrials, and business services. Bridgepoint was formed in 1984 and has offices in London, Frankfurt, Luxembourg, Madrid, Milan, Paris, Stockholm and Warsaw.

DEAL STATS #
Overall 103 of 184
Sector (Medical Products) 3 of 4
Type (Growth Capital) 4 of 18
Country (France) 24 of 41
Year (2015) 7 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-03 Ello Group

Huddersfield, United Kingdom

Ello Group offer discounts to their members at over 10,000 restaurants across the UK in return for annual membership fees. Ello Group is based in Huddersfield, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-02 Quotient Sciences

Nottingham, United Kingdom

Quotient Sciences is a provider of outsourced, early-stage drug development services to the pharmaceutical industry. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. Quotient Sciences is based in Nottingham, England.

Sell -
Mergr

Product

Company

Legal